CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Gutwerg Ori SVP, GENERICS | Sale | −5,084 | $60.00 | $305K | 94,092 |
| 2025-03-05 | Gutwerg Ori SVP, GENERICS | Option exercise · Stock Option (right to buy) | −300 | $31.49 | $9K | 13,204 |
| 2025-02-28 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,099 | $61.89 | $68K | 67,525 |
| 2025-02-28 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes | −1,099 | $61.89 | $68K | 80,945 |
| 2025-02-28 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,275 | $61.89 | $79K | 114,191 |
| 2025-02-28 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,570 | $61.89 | $97K | 99,176 |
| 2025-02-28 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −12,216 | $61.89 | $756K | 502,694 |
| 2025-02-28 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −1,861 | $61.89 | $115K | 192,223 |
| 2025-02-28 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −627 | $61.89 | $39K | 45,465 |
| 2025-02-21 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,000 | $60.20 | $60K | 68,624 |
| 2025-02-15 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,184 | $58.92 | $70K | 115,466 |
| 2025-02-15 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,167 | $58.92 | $69K | 100,746 |
| 2025-02-14 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,196 | $58.92 | $70K | 69,624 |
| 2025-02-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes 10b5-1 | −1,434 | $58.92 | $84K | 82,044 |
| 2025-02-14 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,473 | $58.92 | $87K | 116,650 |
| 2025-02-14 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,426 | $58.92 | $84K | 101,913 |
| 2025-02-14 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −7,799 | $58.92 | $460K | 514,910 |
| 2025-02-14 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −1,730 | $58.92 | $102K | 194,084 |
| 2025-02-14 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −582 | $58.92 | $34K | 46,092 |
| 2025-02-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $59.54 | $24K | 83,478 |
Page 9 of 23 · 442 trades